Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Version 2 2024-06-05, 06:14Version 2 2024-06-05, 06:14
Version 1 2019-11-18, 14:45Version 1 2019-11-18, 14:45
journal contribution
posted on 2024-06-05, 06:14authored byGD Batty, Q Li, Rachel HuxleyRachel Huxley, S Zoungas, BA Taylor, B Neal, B de Galan, M Woodward, SB Harrap, S Colagiuri, A Patel, J Chalmers